The frequency of heterozygous carriage of CFTR gene mutations causing the development of cystic fibrosis in a population-based cohort study (ESSE-Vologda)
E. A. Sotnikova,
M. V. Klimushina,
A. V. Kiseleva,
O. P. Skirko,
O. V. Kurilova,
M. G. Divashuk,
E. Yu. Khlebus,
V. A. Kozlova,
M. S. Pokrovskaya,
P. A. Slominsky,
A. N. Meshkov,
O. M. Drapkina
https://doi.org/10.25557/2073-7998.2020.07.64-65
Abstract
The aim of the study was to create a panel for screening the carriers of mutations associated with the development of cystic fibrosis (CF), and testing the panel on 642 participants of the population-based cohort study (ESSE-Vologda). Variants were detected using the QuantStudio 12K Flex Real-Time PCR system. A custom panel that includes 60 CFTR variants was created. Among 642 participants in the study, 23 heterozygous carriers of 6 CFTR mutations were identified. The carrier frequency was 3.58% (CI95%: 2.28-5.33%) or 1:28. The custom panel can be used for screening heterozygous CF carriers.
About the Authors
E. A. Sotnikova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
M. V. Klimushina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
A. V. Kiseleva
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
O. P. Skirko
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
O. V. Kurilova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
M. G. Divashuk
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
E. Yu. Khlebus
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
V. A. Kozlova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
M. S. Pokrovskaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
P. A. Slominsky
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
A. N. Meshkov
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
For citations:
Sotnikova E.A.,
Klimushina M.V.,
Kiseleva A.V.,
Skirko O.P.,
Kurilova O.V.,
Divashuk M.G.,
Khlebus E.Yu.,
Kozlova V.A.,
Pokrovskaya M.S.,
Slominsky P.A.,
Meshkov A.N.,
Drapkina O.M.
The frequency of heterozygous carriage of CFTR gene mutations causing the development of cystic fibrosis in a population-based cohort study (ESSE-Vologda). Medical Genetics. 2020;19(7):64-65.
(In Russ.)
https://doi.org/10.25557/2073-7998.2020.07.64-65
Views:
503